Skip to main content
Clinical Trials/NCT06186882
NCT06186882
Recruiting
Not Applicable

Gene x Environment Interplay in Developmental Dyslexia Treatment: A Round-trip Translation Between Humans and Animal

IRCCS Eugenio Medea1 site in 1 country60 target enrollmentApril 30, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Reading Disorder
Sponsor
IRCCS Eugenio Medea
Enrollment
60
Locations
1
Primary Endpoint
Rapid automatized naming
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Developmental dyslexia affects 7% of school-age children (Male:Female ratio of 1.5:1) and incurs disadvantages in education and occupation. Scientific progress concerning the etiology of developmental dyslexia evidenced the complex gene-environment interaction. The DCDC2-READ1 deletion associates with reading skills and affects the magnocellular-dorsal stream in humans and animals. DCDC2 modifies neural activity within the excitatory pathways. The magnocellular-dorsal stream mediates the function of the attention network. Difficulties in spatial and temporal attention shifting impair letter-to-speech sound integration increasing neural noise. Action video games improve the efficiency of the magnocellular-dorsal stream. The aim of this cutting-edge, round trip translation study is threefold: 1.to unravel new insights behind the pathophysiology of developmental dyslexia, 2. to assess gene-environment interaction effects on developmental dyslexia endophenotypes, and 3. to identify useful clues to foster the identification of new, personalized treatments.

Registry
clinicaltrials.gov
Start Date
April 30, 2023
End Date
April 30, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
IRCCS Eugenio Medea
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • intelligence quotient below the average range,
  • presence of counter indications for magnetic resonance acquisition,
  • previous diagnosis of any neurodevelopmental disorders.

Outcomes

Primary Outcomes

Rapid automatized naming

Time Frame: 3 years

Rapid automatized naming - assessed by the RAN test. Measures obtained: Z scores age-corrected.

Short-term memory

Time Frame: 3 years

Short-term memory - assessed by the Single Digit Forward Span, Single Digit Backward Span. Measures obtained: Z scores age-corrected.

Phonological awareness

Time Frame: 3 years

Phonological awareness - assessed by the nonword repetition test. Measures obtained: Z scores age-corrected.

Visual motion processing

Time Frame: 3 years

Visual motion processing - assessed by Coherent dot motion task

Reading skills

Time Frame: 3 years

Reading skills - assessed by single unrelated words and pseudo-words reading tests. Measures obtained: Z scores age-corrected.

Visual attention

Time Frame: 3 years

Visual attention - assessed by a computer-based visual attention task

measurement of neurotransmitters

Time Frame: 3 years

in vivo measures of neurotransmitters including glutamate and gamma-Aminobutyric acid magnetic resonance spectroscopy

Study Sites (1)

Loading locations...

Similar Trials